Atopic Dermatitis Drugs Market Outlook 2028 | Revenue Models
The Global Atopic Dermatitis Drugs Market is estimated to reach at high CAGR during the forecast period (2021-2028).
(EMAILWIRE.COM, October 27, 2021 )
Market Overview
Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and result from a complex interplay of environmental, immunological, genetic, and pharmacologic factors. It's common in children but can occur at any age. Atopic dermatitis is long-lasting (chronic) and tends to flare periodically.
View full report: https://bit.ly/3bfoEI2
Market Dynamics
The global atopic dermatitis drug market growth is driven by the increasing prevalence of allergic reactions, including food allergy, rising campaigns for awareness, and high R&D in this field, these factors will drive the global atopic dermatitis drugs market growth in the forecast period.
Growing prevalence of food allergies that are exacerbating atopic dermatitis fuel the market growth
The increasing growth in the global atopic dermatitis drugs market is due to the growing prevalence of food allergies exacerbating atopic dermatitis. Allergy of any kind plays a vital role in the life of a person with atopic dermatitis. This condition generally flares when a person with atopic dermatitis disease is around substances that can cause allergic reactions. Primarily affecting children and infants, atopic dermatitis is estimated to account for around 10 to 20% of those suffering from eczema, according to the data of the American College of Allergy, Asthma & Immunology.
According to research, food allergy and severe atopic dermatitis coexist in approximately one-third of all children with atopic dermatitis. These food allergies are mainly caused by chicken eggs, cow’s milk, peanuts, wheat, nuts, soy, and fish. Also, atopic dermatitis once appeared in childhood can exacerbate with time.
Additionally, skin irritants occur due to certain soaps, detergents, perfumes, etc. Thus, allergic reactions, mainly due to food, are among the significant factors increasing the burden of atopic dermatitis and driving the market growth.
Market Segmentation:
Global Atopic Dermatitis Drugs Market - By Drug class
• Corticosteroids
• Calcineurin Inhibitors
• PDE4 inhibitors
• Biologics
• Other
Global Atopic Dermatitis Drugs Market - By Route of Administration
• Topical
• Injectable
• Oral
Global Atopic Dermatitis Drugs Market -By End User
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Global Atopic Dermatitis Drugs Market - By Region
• North America
• South America
• Europe
• Asia
• Middle East & Africa
Download free sample: https://bit.ly/3CxYE6V
Competitive Landscape
The atopic dermatitis drugs market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Bayer, Sanofi, Pfizer Inc., Novartis International AG, Allergan PLC, Abbvie Inc., Meda Pharmaceuticals, JW Pharmaceutical, Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd., Wuhan Disel Biotechnology Co., Ltd., and Qingdao Hiseeking Enterprises Co., Ltd. among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the atopic dermatitis drugs market globally.
Topic's you may be interested, Astragalus Polysaccharide Market, Serum Separation Gel Market, Atherosclerosis Drugs Market, Biological Multiplex Assays Market, Optical Disorders Drugs Market
Market Overview
Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and result from a complex interplay of environmental, immunological, genetic, and pharmacologic factors. It's common in children but can occur at any age. Atopic dermatitis is long-lasting (chronic) and tends to flare periodically.
View full report: https://bit.ly/3bfoEI2
Market Dynamics
The global atopic dermatitis drug market growth is driven by the increasing prevalence of allergic reactions, including food allergy, rising campaigns for awareness, and high R&D in this field, these factors will drive the global atopic dermatitis drugs market growth in the forecast period.
Growing prevalence of food allergies that are exacerbating atopic dermatitis fuel the market growth
The increasing growth in the global atopic dermatitis drugs market is due to the growing prevalence of food allergies exacerbating atopic dermatitis. Allergy of any kind plays a vital role in the life of a person with atopic dermatitis. This condition generally flares when a person with atopic dermatitis disease is around substances that can cause allergic reactions. Primarily affecting children and infants, atopic dermatitis is estimated to account for around 10 to 20% of those suffering from eczema, according to the data of the American College of Allergy, Asthma & Immunology.
According to research, food allergy and severe atopic dermatitis coexist in approximately one-third of all children with atopic dermatitis. These food allergies are mainly caused by chicken eggs, cow’s milk, peanuts, wheat, nuts, soy, and fish. Also, atopic dermatitis once appeared in childhood can exacerbate with time.
Additionally, skin irritants occur due to certain soaps, detergents, perfumes, etc. Thus, allergic reactions, mainly due to food, are among the significant factors increasing the burden of atopic dermatitis and driving the market growth.
Market Segmentation:
Global Atopic Dermatitis Drugs Market - By Drug class
• Corticosteroids
• Calcineurin Inhibitors
• PDE4 inhibitors
• Biologics
• Other
Global Atopic Dermatitis Drugs Market - By Route of Administration
• Topical
• Injectable
• Oral
Global Atopic Dermatitis Drugs Market -By End User
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Global Atopic Dermatitis Drugs Market - By Region
• North America
• South America
• Europe
• Asia
• Middle East & Africa
Download free sample: https://bit.ly/3CxYE6V
Competitive Landscape
The atopic dermatitis drugs market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Bayer, Sanofi, Pfizer Inc., Novartis International AG, Allergan PLC, Abbvie Inc., Meda Pharmaceuticals, JW Pharmaceutical, Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd., Wuhan Disel Biotechnology Co., Ltd., and Qingdao Hiseeking Enterprises Co., Ltd. among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the atopic dermatitis drugs market globally.
Topic's you may be interested, Astragalus Polysaccharide Market, Serum Separation Gel Market, Atherosclerosis Drugs Market, Biological Multiplex Assays Market, Optical Disorders Drugs Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results